logo
Book a meeting
VGYAAN Pharmaceuticals

Vgyaan Pharmaceuticals

Pharmaceuticals, 23 Orch Rd, Skillman, New Jersey, 08558, United States, 1-10 Employees

vgyaan.com

  • twitter
  • LinkedIn

phone no Phone Number: +16*********

Who is VGYAAN PHARMACEUTICALS

VGYAAN Pharmaceuticals, LLC is a privately held specialty pharmaceutical company concentrated on developing and commercializing clinically critical therapies across a variety of dosage fo...

Read More

lock icon Get Full Access
map
  • 23 Orch Rd, Skillman, New Jersey, 08558, United States Headquarters: 23 Orch Rd, Skillman, New Jersey, 08558, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from VGYAAN PHARMACEUTICALS

VGYAAN Pharmaceuticals Org Chart and Mapping

Employees
Nimisha Bhatt

Nimisha Bhatt

Chief Operating Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for VGYAAN Pharmaceuticals
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding VGYAAN Pharmaceuticals

Answer: VGYAAN Pharmaceuticals's headquarters are located at 23 Orch Rd, Skillman, New Jersey, 08558, United States

Answer: VGYAAN Pharmaceuticals's phone number is +16*********

Answer: VGYAAN Pharmaceuticals's official website is https://vgyaan.com

Answer: VGYAAN Pharmaceuticals's revenue is $1 Million to $5 Million

Answer: VGYAAN Pharmaceuticals's SIC: 2834

Answer: VGYAAN Pharmaceuticals has 1-10 employees

Answer: VGYAAN Pharmaceuticals is in Pharmaceuticals

Answer: VGYAAN Pharmaceuticals contact info: Phone number: +16********* Website: https://vgyaan.com

Answer: VGYAAN Pharmaceuticals, LLC is a privately held specialty pharmaceutical company concentrated on developing and commercializing clinically critical therapies across a variety of dosage forms and therapeutic categories, including generics and 505(b)(2) drugs. The company was formed as a direct result of long term collaborations with key industry stakeholders from across the value chain. We are committed to continue collaborating with a wide range of stakeholders as we pursue our journey of providing valuable drug therapies to patients. In June 2023, VGYAAN was acquired by RK Pharma Inc. - a vertically integrated, global pharmaceutical company with funding from a global private equity group.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access